Abbott (NYSE: ABT) reported Q4 EPS of $1.32, $0.13 better than the analyst estimate of $1.19. Revenue for the quarter came in at $11.5 billion versus the consensus estimate of $10.58 billion.

GUIDANCE:

Abbott sees FY2022 EPS of $4.70, versus the consensus of $4.78.

For earnings history and earnings-related data on Abbott (ABT) click here.